BRN2 suppresses apoptosis, reprograms DNA damage repair, and is associated with a high somatic mutation burden in melanoma
Open accessThe DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
Whether cell types exposed to a high level of environmental insults possess cell type-specific prosurvival mechanisms or enhanced DNA damage repair capacity is not well understood. BRN2 is a tissue-restricted POU domain transcription factor implicated in neural development and several cancers. In melanoma, BRN2 plays a key role in promoting invasion and regulating proliferation. Here we found, surprisingly, that rather than interacting with transcription cofactors, BRN2 is instead associated with DNA damage response proteins and directly binds PARP1 and Ku70/Ku80. Rapid PARP1-dependent BRN2 association with sites of DNA damage facilitates recruitment of Ku80 and reprograms DNA damage repair by promoting Ku-dependent nonhomologous end-joining (NHEJ) at the expense of homologous recombination. BRN2 also suppresses an apoptosis-associated gene expression program to protect against UVB-, chemotherapy- and vemurafenib-induced apoptosis. Remarkably, BRN2 expression also correlates with a high single-nucleotide variation prevalence in human melanomas. By promoting error-prone DNA damage repair via NHEJ and suppressing apoptosis of damaged cells, our results suggest that BRN2 contributes to the generation of melanomas with a high mutation burden. Our findings highlight a novel role for a key transcription factor in reprogramming DNA damage repair and suggest that BRN2 may impact the response to DNA-damaging agents in BRN2-expressing cancers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Global quantification of mammalian gene expression control
Schwanhäusser, B., Busse, D., Li, N., Dittmar, G., Schuchhardt, J., Wolf, J., Chen, W., & Selbach, M. (2011) · Nature · doi:10.1038/nature10098 · Cited by 6,566
Genomic correlates of response to CTLA-4 blockade in metastatic melanoma
Van Allen, E. M., Miao, D., Schilling, B., Shukla, S. A., Blank, C., Zimmer, L., Sucker, A., Hillen, U., Geukes Foppen, M. H., Goldinger, S. M., et al. (2015) · Science · doi:10.1126/science.aad0095 · Cited by 2,839 · cited 1×
“…beusefulindecisionsregardingpatientstratificationfor immunotherapy — where some studies have suggested that a high mutation load may be important (Snyder et al. 2014; Van Allen et al. 2015; Lauss et al. 2017; Morrison et al. 2018) — remains to be determined.”
A landscape of driver mutations in melanoma
Hodis, E., Watson, I. R., Kryukov, G. V., Arold, S. T., Imielinski, M., Theurillat, J.-P., Nickerson, E., Auclair, D., Li, L., Place, C., et al. (2012) · Cell · doi:10.1016/j.cell.2012.06.024 · Cited by 2,610 · cited 1×
“…relevant in melanoma that exhibits an especially high mutational load that is predominantly caused by solar UV irradiation, with the C>T UV mutational signature increasing during melanoma progression (Hodis et al. 2012; Krauthammer et al. 2012; Alexandrov et al. 2013; Shain and Bastian 2016).”
ProteoWizard: open source software for rapid proteomics tools development
Kessner, D., Chambers, M., Burke, R., Agus, D., & Mallick, P. (2008) · Bioinformatics · doi:10.1093/bioinformatics/btn323 · Cited by 2,024
Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma
Krauthammer, M., Kong, Y., Ha, B. H., Evans, P., Bacchiocchi, A., McCusker, J. P., Cheng, E., Davis, M. J., Goh, G., Choi, M., et al. (2012) · Nature Genetics · doi:10.1038/ng.2359 · Cited by 1,191 · cited 1×
“…relevant in melanoma that exhibits an especially high mutational load that is predominantly caused by solar UV irradiation, with the C>T UV mutational signature increasing during melanoma progression (Hodis et al. 2012; Krauthammer et al. 2012; Alexandrov et al. 2013; Shain and Bastian 2016).”
Ever-Changing Landscapes: Transcriptional Enhancers in Development and Evolution
Long, H. K., Prescott, S. L., & Wysocka, J. (2016) · Cell · doi:10.1016/j.cell.2016.09.018 · Cited by 945
PARPs and ADP-ribosylation: recent advances linking molecular functions to biological outcomes
Gupte, R., Liu, Z., & Kraus, W. L. (2017) · Genes & Development · doi:10.1101/gad.291518.116 · Cited by 681 · cited 1×
“PARP, one of the early DNA damage response proteins, is required for recruitment of a specific subset of DDR proteins to sites of DNA damage (Dantzer et al. 2006; Gupte et al. 2017).”
Lukas, J., Lukas, C., & Bartek, J. (2011) · Nature Cell Biology · doi:10.1038/ncb2344 · Cited by 645 · cited 1×
“…ATM, ATR, and DNA-PK CS leads to phosphorylation at Ser139 ( γ H2AX) of the histone protein H2AX that is propagated along the chromatin producing large, extensive foci that can be assayed by immunofluorescence using confocal microscopy or FACS (Huang and Darzynkiewicz 2006; Lukas et al. 2011).”
Hierarchical Mechanisms for Direct Reprogramming of Fibroblasts to Neurons
Wapinski, O. L., Vierbuchen, T., Qu, K., Lee, Q. Y., Chanda, S., Fuentes, D. R., Giresi, P. G., Ng, Y. H., Marro, S., Neff, N. F., et al. (2013) · Cell · doi:10.1016/j.cell.2013.09.028 · Cited by 627 · cited 1×
“…BRN2 genome-wide binding during neuronal reprogramming did not reveal significant binding of BRN2 to the apoptosis-associated genes identified here as deregulated by BRN2 silencing, with the exception of BCL2 (Lodato et al. 2013; Wapinski et al. 2013; Mistri et al. 2015; Xue et al. 2016).”
Research works printed but not linked: 89
- 10.1038/nature12477 · DOI · Paper page
- 10.1016/j.stem.2011.07.002 · DOI · Paper page
- 10.1210/er.22.1.2 · doi:10.1210/er.22.1.2
- 10.1016/j.ccr.2010.10.029 · DOI · Paper page
- 10.1093/nar/28.1.235 · DOI · Paper page
- 10.1016/j.ejcb.2013.10.001 · DOI
- 10.1111/j.1755-148X.2011.00862.x · DOI
- 10.1016/j.molcel.2005.04.015 · DOI · Paper page
- 10.1158/2159-8290.CD-15-1263 · DOI · Paper page
- 10.1016/j.molcel.2017.05.015 · DOI · Paper page
- 10.1128/MCB.01067-12 · DOI
- 10.1111/j.1755-148X.2011.00849.x · DOI · Paper page
- 10.4161/cc.10.8.15341 · DOI
- 10.1016/j.celrep.2015.09.057 · DOI
- 10.1111/j.1755-148X.2008.00510.x · DOI
- 10.1016/S0076-6879(05)09029-4 · DOI · Paper page
- 10.1097/PPO.0b013e31824d448c · DOI · Paper page
- 10.1093/bioinformatics/bth078 · DOI · Paper page
- 10.1002/pmic.200900375 · DOI · Paper page
- 10.1111/j.1600-0781.1997.tb00110.x · DOI · Paper page
- 10.1093/bioinformatics/bts635 · DOI · Paper page
- 10.1007/s00894-016-3078-x · doi:10.1007/s00894-016-3078-x
- 1995, The POU domain transcription factor Brn-2: elevated expression in malignant melanoma and regulation of melanocyte-specific gene expression, Oncogene, 11, 2157
- 10.1101/gad.290940.116 · DOI · Paper page
- 10.1016/j.ebiom.2017.01.013 · DOI
- 10.1111/pcmr.12710 · DOI
- 10.1016/0896-6273(93)90231-F · DOI
- 10.1158/0008-5472.CAN-08-1053 · DOI · Paper page
- 10.1128/MCB.24.7.2915-2922.2004 · DOI
- 10.1128/MCB.24.7.2923-2931.2004 · DOI
- 10.4161/cc.4.2.1486 · DOI · Paper page
- 10.1186/1471-2105-14-7 · DOI · Paper page
- 10.1111/j.1755-148X.2010.00757.x · DOI · Paper page
- 10.1093/nar/gky1159 · DOI · Paper page
- 10.1385/1-59259-973-7:073 · DOI · Paper page
- 10.1111/pin.12042 · DOI
- 10.1016/j.celrep.2015.04.053 · DOI · Paper page
- 10.1038/cdd.2017.179 · DOI · Paper page
- 10.1038/labinvest.2017.9 · DOI · Paper page
- 10.1101/gad.11.6.701 · DOI · Paper page
- 10.1038/nmeth.4330 · DOI · Paper page
- 10.1111/j.1755-148X.2010.00697.x · DOI · Paper page
- 10.1093/nar/gkx1128 · DOI
- 10.1016/j.jprot.2013.12.022 · DOI
- 10.1016/j.jprot.2014.09.011 · DOI · Paper page
- 10.1007/978-1-61779-270-0_13 · DOI
- 10.1038/s41467-017-01460-0 · DOI · Paper page
- 10.1038/sj.onc.1204923 · DOI
- 10.1038/nrm1202 · DOI · Paper page
- 10.1016/j.jprot.2016.04.042 · DOI · Paper page
- 10.1371/journal.pgen.1003288 · DOI · Paper page
- 10.1038/s41467-018-02893-x · DOI · Paper page
- 10.1016/j.jmb.2017.03.024 · DOI · Paper page
- 10.14806/ej.17.1.200 · DOI · Paper page
- 10.1016/S0092-8674(02)00762-6 · DOI · Paper page
- 10.1038/nprot.2013.092 · DOI · Paper page
- 10.15252/embr.201540467 · DOI · Paper page
- 10.1186/s40425-018-0344-8 · DOI · Paper page
- 10.1101/gad.9.24.3109 · DOI · Paper page
- 10.1006/jmbi.2000.4042 · DOI · Paper page
- 10.1002/ijc.10275 · DOI
- 10.1002/jcc.20084 · DOI · Paper page
- 10.1006/jmbi.2000.4107 · DOI · Paper page
- 10.1158/0008-5472.CAN-09-0781 · DOI · Paper page
- 10.1097/CMR.0b013e32830d8329 · DOI
- 10.1093/bioinformatics/btp616 · DOI · Paper page
- 10.1101/gad.11.10.1207 · DOI · Paper page
- 10.1093/bioinformatics/bth349 · DOI · Paper page
- 10.1101/gad.9.24.3122 · DOI · Paper page
- 10.1093/nar/18.18.5495 · DOI · Paper page
- 10.1038/nrc.2016.37 · DOI · Paper page
- 10.1056/NEJMoa1502583 · DOI · Paper page
- 10.1101/gr.1239303 · DOI · Paper page
- 10.1074/mcp.M111.007690 · DOI · Paper page
- 10.1038/s41598-017-11366-y · DOI
- 10.1046/j.1432-1327.2000.01737.x · DOI
- 10.1056/NEJMoa1406498 · DOI · Paper page
- 10.1074/jbc.271.29.17512 · DOI
- 10.1016/B978-0-12-405881-1.00002-1 · DOI · Paper page
- 10.1158/0008-5472.CAN-04-1399 · DOI · Paper page
- 10.1074/jbc.M115.694992 · DOI
- 10.1016/j.cell.2006.07.024 · DOI · Paper page
- 10.1016/j.jprot.2013.10.023 · DOI · Paper page
- 10.1038/onc.2011.33 · DOI · Paper page
- 10.1126/science.aad0501 · DOI · Paper page
- 10.1023/A:1006855632268 · DOI
- 10.1371/journal.pone.0002734 · DOI · Paper page
- 10.1016/j.ccell.2018.05.014 · DOI · Paper page
- 10.1089/scd.2017.0250 · DOI
Cited by
Diversity and versatility of p38 kinase signalling in health and disease
Canovas, B., & Nebreda, A. R. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00322-w · Cited by 657
G-quadruplexes: a promising target for cancer therapy
Kosiol, N., Juranek, S., Brossart, P., Heine, A., & Paeschke, K. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01328-4 · Cited by 533
Goding, C. R., & Arnheiter, H. (2019) · Genes & Development · doi:10.1101/gad.324657.119 · Cited by 430
Self-citationTEAD Proteins Associate With DNA Repair Proteins to Facilitate Cellular Recovery From DNA Damage
Calses, P. C., Pham, V. C., Guarnaccia, A. D., Choi, M., Verschueren, E., Bakker, S. T., Pham, T. H., Hinkle, T., Liu, C., Chang, M. T., et al. (2023) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2023.100496 · Cited by 22
Metadata
- Authors
- Herbert, K., Binet, R., Lambert, J.-P., Louphrasitthiphol, P., Kalkavan, H., Sesma-Sanz, L., Robles-Espinoza, C. D., Sarkar, S., Suer, E., Andrews, S., Chauhan, J., Roberts, N. D., Middleton, M. R., Gingras, A.-C., Masson, J.-Y., Larue, L., Falletta, P., & Goding, C. R.
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2019-02-25
- Volume
- 33
- Issue
- 5-6
- Pages
- 310-332
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- OpenAlex
- W2916900413
- Cited by
- 45
- References
- 20
- Type
- posted content
- Language
- en
- Open access
- diamond
- Funders
- Wellcome Trust (106288/Z/14/Z, 204562/Z/16/Z)
- Ludwig Institute for Cancer Research
- National Institutes of Health (PO1 CA128814-06A1)
- Canadian Institutes of Health Research (FDN 143301)
- National Institute for Health Research Biomedical Research Centre, Oxford
- Universidad Nacional Autonoma de Mexico (IA200318)
- Deutsche Forschungsgemeinschaft (392470008)
- Cancer Research Society (22779)
- Fonds de Recherche du Québec-Santé
- Fondation ARC
- La Ligue National Contre le Cancer
- Institut National du Cancer
- Institut Thématique Multi-Organisme Cancer
- CIHR Foundation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: BRN2 suppresses apoptosis, reprograms DNA damage repair, and is associated with a high somatic mutation burden in melanoma. https://app.cochat.ai/papers/10.1101/gad.314633.118
- The paper
- Herbert, K., Binet, R., Lambert, J.-P., Louphrasitthiphol, P., Kalkavan, H., Sesma-Sanz, L., Robles-Espinoza, C. D., Sarkar, S., Suer, E., Andrews, S., Chauhan, J., Roberts, N. D., Middleton, M. R., Gingras, A.-C., Masson, J.-Y., Larue, L., Falletta, P., & Goding, C. R. (2019). BRN2 suppresses apoptosis, reprograms DNA damage repair, and is associated with a high somatic mutation burden in melanoma. Genes & Development. https://doi.org/10.1101/gad.314633.118
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.